Clavulin Tablet 625mg/ Pk

Description

CLAVULIN TABLET 625MG
This medication is indicated for the treatment of the following infections when caused by susceptible strains of the designated bacteria: Sinusitis when caused by β-lactamase-producing strains of H. influenzae or Moraxella (Branhamella) catarrhalis. Otitis Media when caused by β-lactamase-producing strains of H. influenzae or Moraxella (Branhamella) catarrhalis. Lower Respiratory Tract Infections when caused by β-lactamase-producing strains of H. influenzae, K. pneumoniae, S. aureus, or Moraxella (Branhamella) catarrhalis. Skin and Soft Tissue Infections when caused by β-lactamase-producing strains of S. aureus. Urinary Tract Infections when caused by β-lactamase-producing strains of E. coli.

ADDED INFORMATION
It also contains colloidal silica, dimethicone 500, hydroxypropyl methylcellulose (Methocel E5), hydroxypropyl methylcellulose (Methocel E15), magnesium stearate, etc.

CONTRAINDICATIONS
Hypersensitivity to any of the ingredients
Infectious mononucleosis either suspected or confirmed.
A previous history of amoxicillin-associated jaundice/hepatic dysfunction.

DOSAGE
For mild to moderate infections, the usual adult dose is one 625mg tablet every 12 hours.
For more severe infections (including chronic and recurrent urinary tract infections and infections of the lower respiratory tract), the dose should be one 1000 mg tablet every 12 hours or one 625mg tablet every 8 hours.

POSSIBLE SIDE EFFECTS
This drug may cause stomach and abdominal pain, vomiting, and diarrhea, as well as rash, hyperactivity, or drowsiness. Please report to the pharmacist or physician if side effects worsen or last more than a few days.

WARNING
Prolonged use may lead to supra-infections
Prolonged use may also occasionally result in overgrowth of non-susceptible organisms.

STORAGE
Store below 30oC.  Protect from sunlight and heat.